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vABSTRACT
Thiophene chalcones, pyrazolines and 1,5-benzodiazepines are important 
heterocyclic compounds which show broad spectrum of biological activities. Three 
series o f heterocyclic chalcones and their A-acetylated pyrazoline derivatives have 
been synthesized in low to good yields. The first step in this study is the synthesis of 
3-acetyl-2,5-dichlorothiophene and 2-acetyl-5-chlorothiophene as heterocyclic 
ketones using Friedel-Crafts acylation. All thiophene chalcones were synthesized in 
three separate reactions by Claisen-Schmidt reaction o f substituted thiophene 
aldehydes with ketones. Several acetophenone derivatives (series 2 and 3) were 
produced by cyclization reaction using hydrazine hydrate to form new and known A - 
acetylated pyrazoline derivatives. A series o f substituted 1,5-benzodiazepines were 
synthesized in moderate to good yields. 4-Methyl-1,3,4,5-tetrahydro-2#-1,5- 
benzodiazepin-2-one was synthesized as starting material by reacting ortho 
phenylenediamine and crotonic acid in the presence of toluene. Cyclization of the 
starting material with appropriate acid chlorides, unsubstituted and five types o f  
groups (fluoro, chloro, bromo, methyl and methoxy) attached at ortho, para  and meta 
position of phenyl ring in the presence of triethylamine and anhydrous 
tetrahydrofuran have furnished substituted 1,5-benzodiazepines. The structures of the 
compounds were confirmed by infrared (IR), !H NMR and 13C NMR (1D and 2D) 
nuclear magnetic resonance spectroscopies. Compounds of series 2 and 3 were tested 
for their antifungal activities against two types of pathogenic strains, namely 
Candida albicansa and Aspergillus niger with fluconazole as 
standard drug. The results for series 2 showed that the presence o f bromo and 
methoxy substitution at para  position on phenyl ring in chalcone and pyrazoline, 
respectively, resulted in significant enhancement in potency against both tested 
fungal strains with MIC value of >64 |ig/mL. Compound carrying para  fluoro on 
phenyl ring in pyrazoline derivatives exhibited the highest potency with MIC value 
of >32 |ig/mL and 64 |ig/mL against C. albicans and A.niger, respectively, among 
the series 3. The anti-HIV-1 RT assay of substituted 1,5-benzodiazepines (series 4) 
showed that the presence o f chloro substitution at meta and ortho position inhibited 
the activity o f HIV-1 RT with IC5o values 6.87 and 8.62 |iM, respectively.
vi
ABSTRAK
Tiofena kalkon, pirazolina dan 1,5-benzodiazepina adalah sebatian heterosiklik 
penting yang menunjukkan aktiviti biologi yang pelbagai. Tiga siri heterosiklik 
kalkon dan terbitan A-asetil pirazolina telah disintesis dengan hasil yang rendah 
hingga hasil yang baik. Langkah pertama dalam kajian ini ialah sintesis 3-asetil-2,5- 
diklorotiofena dan 2-asetil-5-klorotiofena sebagai keton heterosiklik menggunakan 
pengasilan Friedel-Crafts. Semua tiofena kalkon disintesis dalam tiga tindak balas 
berasingan dengan tindak balas Claisen-Schmidt aldehid tiofena tertukar ganti 
dengan keton. Beberapa terbitan asetofenon (siri 2 dan 3) telah dihasilkan dengan 
tindak balas pensiklikan menggunakan hidrazina hidrat untuk menghasilkan terbitan 
pirazolina A-asetil yang baharu dan yang diketahui. Satu siri 1,5-benzodiazepina 
tertukar ganti telah disintesis dengan hasil yang sederhana hingga hasil yang baik. 4- 
Metil-1,3,4,5-tetrahidro-2#-1,5-benzodiazepin-2-on telah dihasilkan sebagai bahan 
pemula melalui tindak balas orto fenilenadiamina dan asid krotonik dengan 
kehadiran toluena. Pensiklikan bahan pemula itu dengan asid klorida yang sesuai, 
fenil tanpa penukarganti dan gelang fenil dengan lima jenis kumpulan (fluoro, kloro, 
bromo, metil dan metoksi) yang terikat pada kedudukan orto, para  dan meta dengan 
kehadiran trietilamina dan tetrahidrofuran kontang telah menghasilkan 1,5- 
benzodiazepina tertukar ganti. Struktur sebatian disahkan dengan spektroskopi 
inframerah (IR) dan resonans magnet nucleus 1H NMR dan 13C NMR (1D dan 2D). 
Sebatian siri 2 dan 3 telah diuji untuk aktiviti antikulat terhadap dua jenis patogen, 
iaitu Candida albicansa dan Aspergillus niger dengan flukonazol digunakan sebagai 
dadah piawai. Keputusan bagi siri 2 menunjukkan bahawa kehadiran bromin dan 
metoksi masing-masing pada kedudukan para pada gelang fenil dalam kalkon dan 
pirazolina, menghasilkan peningkatan ketara dalam potensi terhadap kedua-dua 
strain kulat yang diuji dengan nilai MIC > 64 pg/mL. Sebatian yang mengandungi 
fluoro para  pada gelang fenil dalam terbitan pirazolina mempamerkan potensi 
tertinggi dengan nilai MIC 32 pg/mL dan 64 pg/mL masing-masing terhadap C. 
albicans dan A.niger dalam siri 3. Pengujian anti-HIV-1 RT terhadap 1.5- 
benzodiazepin tertukar ganti (siri 4) menunjukkan bahawa kehadiran kloro pada 
kedudukan meta dan orto merencatkan aktiviti HIV-1 RT masing-masing dengan 
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IR spectrum of 1-(5-(3-methylthiophen-2-yl)-3-(4- 
nitrophenyl)-4,5-dihydro- 1H-pyrazol-1 -yl)ethanone
(299)
1H NMR spectrum of 1-(5-(3-methyl thiophen-2-yl)-
3 -(4-nitrophenyl)-4,5-di hydro- 1H-pyrazol-1 -yl) 
ethanone (299)
13 C NMR spectrum of 1-(5-(3-methyl thiophen-2- 
yl)-3 -(4-nitrophenyl)-4,5-dihydro- 1H-pyrazol-1 -yl) 
ethanone (299)
IR spectrum of 4-methyl-1,3,4,5-tetrahydro -2H-1,5- 
benzodiazepin-2-one (199)
1H NMR spectrum of 4-methyl-1,3,4,5-tetrahydro-2H 
-1,5-benzodiazepin-2-one (199)
IR spectrum of 5-(benzoyl)-4-methyl-1,3, 4,5 -tetra 
hydro-2H- 1,5-benzodiazepin-2-one (316)
1H NMR spectrum of 5-(benzoyl)-4-methyl-1,3,4,5- 
tetrahydro-2H-1,5-benzo diazepin-2-one (316)
13 C NMR spectrum of 5-(benzoyl)-4-methyl-1,3,4,5- 
tetrahydro-2H-1,5-benzo diazepin-2-one (316)
IR spectrum of 5-(2-chlorobenzoyl)-4-methyl-
1.3.4.5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one (317) 
1H NMR spectrum of 5-(2-chlorobenzoyl)-4-methyl-
1.3.4.5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one (317)
xlv
175 Expansion o f 1H NMR spectrum of 5-(2-chloro 327
benzoyl)-4-methyl- 1,3,4,5-tetra hydro-2H- 1,5-benzo 
diazepin-2-one (317)
176 13 C NMR spectrum of 5-(2-chloro benzoyl)-4-methyl 328
-1,3,4,5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one
(317)
177 IR spectrum of 5-(3-chlorobenzoyl)-4-methyl- 328
1.3.4.5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one (318)
178 1H NMR spectrum of 5-(3-chlorobenzoyl) -4-methyl 329
-1,3,4,5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one
(318)
179 Expansion of 1H NMR spectrum of 5-(3-chlorobenzo 329
yl)-4-methyl-1,3,4,5 -tetra hydro-2H-1, 5 -benzo 
diazepin-2-one (318)
180 13 C NMR spectrum of 5-(3-chlorobenzoyl)-4-methyl 330
-1,3,4,5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one
(318)
181 IR spectrum of 5-(4-chlorobenzoyl)-4-methyl-1,3 ,4 330
,5-tetrahydro-2H-1,5-benzo diazepin-2-one (319)
182 1H NMR spectrum of 5-(4-chloro benzo yl)-4-methyl 331
-1,3,4,5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one
(319)
183 Expansion o f 1H NMR spectrum of 5-(4-chloro 331
benzoyl)-4-methyl- 1,3,4,5-tetra hydro-2H- 1,5-benzo 
diazepin-2-one (319)
184 13 C NMR spectrum of 5-(4-chlorobenzoyl)-4-methyl 332
-1,3,4,5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one
(319)
185 IR spectrum of 5-(2-fluorobenzoyl)-4-methyl-1,3,4,5- 332
tetrahydro-2H-1,5-benzo diazepin-2-one (320)
186 1H NMR spectrum of 5-(2-fluorobenzoyl)-4-methyl- 333
1.3.4.5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one (320)
187 Expansion of 1H NMR spectrum of 5-(2-fluorobenzo 333
xlvi
yl)-4-methyl-1,3,4,5 -tetra hydro-2H-1, 5 -benzodi 
azepin-2-one (320)
188 13 C NMR spectrum of 5-(2-fluoro benzoyl)-4-methyl 334
-1,3,4,5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one
(320)
189 IR spectrum of 5-(3-fluorobenzoyl)-4-methyl-1,3,4,5- 334
tetrahydro-2H-1,5-benzo diazepin-2-one (321)
190 1H NMR spectrum of 5-(3-fluorobenzoyl)-4-methyl- 335
1.3.4.5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one (321)
191 Expansion of 1H NMR spectrum of 5-(3 -fluorobenzo 335
yl)-4-methyl- 1,3,4,5-tetrahydro-2H- 1,5-benzodi 
azepin-2-one (321)
192 13 C NMR spectrum of 5-(3-fluorobenzoyl) -4-methyl 336
-1,3,4,5 -tetrahydro-2H-1, 5 -benzo diazepin-2-one
(321)
193 IR spectrum of 5-(4-fluorobenzoyl)-4-methyl-1,3,4,5- 336
tetrahydro-2H-1,5-benzo diazepin-2-one (322)
194 1H NMR spectrum of 5-(4-fluorobenzoyl)-4-methyl- 337
1.3.4.5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one (322)
195 Expansion of 1H NMR spectrum of 5-(4-fluorobenzo 337
yl)-4-methyl-1,3,4,5 -tetra hydro-2H-1, 5 -benzodi 
azepin-2-one (322)
196 13 C NMR spectrum of 5-(4-fluorobenzoyl)-4-methyl 338
-1,3,4,5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one
(322)
197 IR spectrum of 5-(2-bromobenzoyl)-4-methyl-1,3,4 ,5 338
-tetrahydro-2H-1,5-benzo diazepin-2-one (323)
198 1H NMR spectrum of 5-(2-bromobenzoyl)-4-methyl- 339
1.3.4.5 -tetrahydro-2H-1, 5 -benzo diazepin-2-one
(323)
199 Expansion of 1H NMR spectrum of 5-(2-bromo benzo 339















13 C NMR spectrum of 5-(2-bromobenzoyl)-4-methyl 340
-1,3,4,5 -tetra hydro-2H- 1,5-benzodiazepin-2-one
(323)
IR spectrum of 5-(3-bromobenzoyl)-4-methyl-1,3,4 ,5 340
-tetrahydro-2H-1,5-benzo diazepin-2-one (324)
1H NMR spectrum of 5-(3-bromobenzoyl)-4-methyl- 341
1.3.4.5 -tetrahydro-2H-1, 5 -benzo diazepin-2-one
(324)
Expansion of 1H NMR spectrum of 5-(3-bromobenzo 341
yl)-4-methyl-1,3,4,5 -tetra hydro-2H-1, 5 -benzodi 
azepin-2-one (324)
13 C NMR spectrum of 5-(3-bromobenzoyl)-4-meth 342
yl- 1,3,4,5-tetrahydro-2H- 1,5-benzodiazepin-2-one
(324)
IR spectrum of 5-(4-bromobenzoyl)-4-methyl-1,3,4 ,5 342
-tetrahydro-2H-1,5-benzo diazepin-2-one (325)
1H NMR spectrum of 5-(4-bromobenzoyl)-4-methyl- 343
1.3.4.5 -tetrahydro-2H-1, 5 -benzo diazepin-2-one
(325)
Expansion of 1H NMR spectrum of 5-(4-bromobenzo 343
yl)-4-methyl-1,3,4,5 -tetra hydro-2H-1, 5 -benzodi 
azepin-2-one (325)
13 C NMR spectrum of 5-(4-bromobenzoyl)-4-methyl 344
-1,3,4,5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one
(325)
IR spectrum of 5-(2-methoxybenzoyl)-4-methyl-1,3 344
,4,5-tetrahydro-2H-1,5- benzo diazepin-2-one (326)
1H NMR spectrum of 5-(2-methoxybenzoyl)-4-meth 345
yl- 1,3,4,5-tetrahydro-2H-1,5- benzodiazepin-2-one
(326)
Expansion of 1H NMR spectrum of 5-(2-methoxy 345















13 C NMR spectrum of 5-(2-methoxybenzoyl)-4- 346
methyl- 1,3,4,5-tetrahydro-2H-1,5- benzodiazepin-2- 
one (326)
IR spectrum of 5-(3-methoxybenzoyl)-4-methyl-1,3,4 346
,5-tetrahydro-2H-1,5-benzo diazepin-2-one (327)
1H NMR spectrum of 5-(3-methoxybenzo yl)-4-meth 347
yl- 1,3,4,5-tetrahydro-2H- 1,5-benzodiazepin-2-one
(327)
Expansion of 1H NMR spectrum of 5-(3-methoxy 347
benzoyl)-4-methyl- 1,3,4,5-tetra hydro-2H- 1,5-benzo 
diazepin-2-one (327)
13 C NMR spectrum of 5-(3-methoxybenzoyl)-4- 348
methyl-1,3,4,5 -tetrahydro-2H-1,5 -benzodiazepin-2- 
one (327)
IR spectrum of 5-(4-methoxybenzoyl)-4-methyl-1,3 348
,4,5-tetrahydro-2H-1,5-benzo diazepin-2-one (328)
1H NMR spectrum of 5-(4-methoxybenzoyl)-4- 349
methyl-1,3,4,5 -tetrahydro-2H-1,5 -benzodiazepin-2- 
one (328)
Expansion of 1H NMR spectrum of 5-(4-methoxy 349
benzoyl)-4-methyl- 1,3,4,5-tetra hydro-2H- 1,5-benzo 
diazepin-2-one (328)
13C NMR spectrum of 5-(4-methoxybenzoyl)-4- 350
methyl-1,3,4,5 -tetrahydro-2H-1,5 -benzodiazepin-2- 
one (328)
DEPT spectra of 5-(4-methoxybenzoyl)-4-methyl-1,3 350
,4,5-tetrahydro-2H-1,5-benzo diazepin-2-one (328)
COSY spectrum of 5-(4-methoxy benzo yl)-4-methyl 351
-1,3,4,5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one
(328)
Expansion of COSY spectrum of 5-(4-methoxybenzo 351















HMQC spectrum of 5-(4-methoxybenzoyl)-4-methyl- 352
1.3.4.5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one (328)
Expansion of HMQC spectrum of 5-(4-methoxy 352
benzoyl)-4-methyl-1,3,4,5 -tetrahydro-2H-1, 5 -benzo 
diazepin-2-one (328)
HMBC spectrum of 5-(4-methoxybenzoyl) -4-methyl 353
-1,3,4,5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one
(328)
Expansion of HMBC spectrum of 5-(4-methoxy 353
benzoyl)-4-methyl-1,3,4,5 -tetrahydro-2H-1, 5 -benzo 
diazepin-2-one (328)
IR spectrum of 5-(2-methylbenzoyl)-4-methyl-1,3,4 354
,5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one (329)
1H NMR spectrum of 5-(2-methylbenzoyl) -4-methyl- 354
1.3.4.5 -tetrahydro-2H-1, 5 -benzo diazepin-2-one
(329)
Expansion o f 1H NMR spectrum of 5-(2-methyl 355
benzoyl)-4-methyl- 1,3,4,5-tetra hydro-2H- 1,5-benzo 
diazepin-2-one (329)
13 C NMR spectrum of 5-(2-methylbenzoyl)-4-methyl 355
-1,3,4,5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one
(329)
IR spectrum of 5-(3-methylbenzoyl)-4-methyl-1,3,4,5 356
-tetrahydro-2H-1,5-benzodiazepin-2-one (330)
1H NMR spectrum of 5-(3-methylbenzoyl) -4-methyl- 356
1.3.4.5 -tetrahydro-2H-1, 5 -benzo diazepin-2-one
(330)
Expansion o f 1H NMR spectrum of 5-(3-methyl 357
benzoyl)-4-methyl-1,3,4,5 -tetrahydro-2H-1, 5 -benzo 
diazepin-2-one (330)
13C NMR spectrum of 5-(3-methylbenzoyl)-4- 357






IR spectrum of 5-(4-methylbenzoyl)-4-methyl-1,3,4,5 358
-tetrahydro-2H-1,5-benzodiazepin-2-one (331)
1H NMR spectrum of 5-(4-methylbenzoyl) -4-methyl- 358
1,3,4,5 -tetrahydro-2H-1, 5 -benzodiazepin-2-one (331)
Expansion o f 1H NMR spectrum of 5-(4-methyl 359
benzoyl)-4-methyl-1,3,4,5 -tetrahydro-2H-1, 5 -benzo 
diazepin-2-one (331)
13C NMR spectrum of 5-(4-methylbenzoyl)-4- 359





1.1 Background of Study
Organic chemistry has a wide range o f applications in various fields such as 
biology, medicine and pharmacology, polymer technology, agriculture and petroleum 
engineering (Carey and Sundberg, 2000).
Heterocyclic chemistry is one o f the branches in organic chemistry. The 
heterocyclic compounds contain atom either one or more atom in addition to carbon, 
such as nitrogen, oxygen or sulphur (Morrison and Boyd, 2002). The heterocyclic 
compounds provide a wide range of biological activities especially in medicine or 
pharmaceutical chemistry and industrial applications such as construction and 
agriculture. In addition heterocyclic chemistry plays important role in our life 
(Katritzky et al., 2010).
Chalcones and heterocyclic chalcone derivatives play important roles against 
diverse human diseases like as anti-inflammatory (Won et al., 2005); (Vogel et al.,
2010); anti-leishmanial (Kayser and Kiderlen, 2001); (Aponte et al., 2010); (De 
Mello et al., 2014); anti-malarial (Wu et al., 2002); (Tadigoppula et al., 2012); anti- 
fungal(Ameta et al., 2011); anti-oxidant (Ahmad et al., 2011); (Doan and Tran,
2011); anti-cancer (Bandgar et al., 2010); (Syam et al., 2012); anti-AIDS agents (Wu
2et al., 2003); (Cheenpracha et al., 2006) and anti-bacterial(Asiri and Khan, 2011); 
(Nowakowska et al., 2008).
Chalcones are synthesized by condensation between aldehydes and ketones. 
Chalcone is one of important intermediate in synthesis of five, six and seven 
membered ring (Kaur and Kishore, 2013) such as isoxazole, pyrazole (five member 
ring) and thiazine, oxazine (six member ring) (Kalirajan et al., 2009) and 
benzodiazepine (seven member ring) (Bhatia et al., 2008). In addition chalcones can 
be used as an intermediate in the biosynthesis of flavonoids (Avila et al., 2008).
In this work, three series of thiophene chalcones were synthesized from 
different heterocyclic ketones or aromatic ketones and different heterocyclic 
aldehydes via base catalyzed Claisen-Schmidt reaction. The thiophene chalcones 
were subjected to cyclocondensation reaction by using hydrazine hydrate in glacial 
acetic acid to give three series of A-acetylated pyrazoline derivatives.
Pyrazoline moiety is a five membered heterocyclic ring associated with a 
large number of pharmaceutical properties such as anti-inflammatory (Gokhan- 
Kelek9 i et al., 2007), antifungal (Zhang et al., 2010); (Hassan, 2013); (Oliveira et al., 
2014), anti malaria (Bekhit et al., 2012); (Cunico et al., 2006), antibacterial 
(Dabholkar and Ansari, 2009); (Liu et al., 2014); (Hassan, 2013), antioxidant (Jois et 
al., 2014) and against depression (Das et al., 2012).
According their biological activities, there are a large number of pyrazoline 
derivatives using diverse synthetic methods reported in literature. These methods 
include cyclization of chalcones with diazomethane (Levai, 1997), aminoguanidine 
hydrochloride (Dos Santos et al., 2017), thiosemicarbazide (Gomha et al., 2017), 
phenyl hydrazine (Khan et al., 2014) and semicarbazide (Das et al., 2012).
The next project is synthesis of benzodiazepine derivatives. Benzodiazepines 
moiety is a seven membered heterocyclic ring attracting widespread attention due to 
variety of applications and biological activities exhibited by derivatives of this
3moiety. They are mostly used in treatment of anxiety, insomnia, muscle spasms and 
epilepsy (Wildmann et al., 1988). Benzodiazepines derivatives also exhibited 
cytotoxic activity against human cancer like colon cancer, lung cancer, breast cancer 
and bladder cancer (Nawrocka et al., 2001a), analgesic, anti-inflammatory (Roma et 
al., 1991), antileukemic (Krezel and Graczyk, 1998) and antimicrobial (Babu et al., 
2014).
1.2 Problem Statement
Fungal infections are considered critical types of health problems infecting 
humans’ health round the world (Turan-Zitouni et al., 2005); (Pilmis et al., 2016); 
(Campoy and Adrio, 2017); (Revie et al., 2018). There are many available antibiotics 
for example fluconazole, voriconazole, itraconazole, Posaconazole, micafungin, 
flucytosine and caspofungin (Nivoix et al., 2008); (Arendrup et al., 2013) that serve 
in killing, weakening or inhibiting fungi and other microbes. Yet, these drugs lead to 
the emergence o f pathogens that are resistant to pharmaceutical drug (Zervos et al., 
1994); (Kathiravan et al., 2012); (Ogundeji et al., 2016); (Campoy and Adrio, 2017); 
(Revie et al., 2018). Moreover, there are many drugs against fungal but they have 
side effects such as phlebitis, rash, fever and other gastrointestinal symptoms such as 
(nausea, vomiting, abdominal and diarrhea) (Torres et al., 2005); (Petrikkos and 
Skiada, 2007); (Kathiravan et al., 2012) and sometimes inactive against certain kinds 
of fungal microorganisms (Ogundeji et al., 2016). Similarly, human
immunodeficiency virus (HIV) epidemic is regarded a serious health problem that 
effects humans’ health worldwide (Singh and Bodiwala, 2010); (Casano et al., 
2010); (Maartens et al., 2014). In addition, drug resistance (Carr and Cooper, 2000); 
(Hopkins et al., 2006); (Breckenridge, 2009); (Sarafianos et al., 2009); (Adamson 
and Freed, 2010); (Rizvi et al., 2014) and side effects of anti HIV drugs came into 
the limelight in the world (Breckenridge, 2009). For instance, there are some side 
effects associated with the combination therapies such as renal failure, hypokalemia, 
abdominal pain, vomiting, diarrhea, nausea, decrease appetite, rash, headache, 
fatigue (Chesney et al., 2000); (Portman, 2018) as well as some CAN symptoms 
such as depression and suicidal ideation (Cihlar and Fordyce, 2016).
4So, the emergence of drug resistance in microorganisms and HIV and side 
effects of drugs are major challenges that scientists face. Such challenges have led to 
searching , exploring and modifying molecules to get novel antifungal and anti-HIV 
agents.
Thiophene chalcones with its derivatives carrying 2-acetylated pyrazoline and
1,5-benzodiazepine derivatives are reported to have a broad of significant biological 
activities including antifungal and anti-HIV, respectively. Taking into consideration 
the importance of the therapeutic uses of these compounds in treatment of fungal and 
HIV, it is clear that synthesizing and designing new compounds is needed to be 
explored for their pharmacological properties, namely being against fungal and HIV.
In this study, four series have been synthesized which are thiophene chalcones 
with its derivatives and benzodiazepine derivatives. The synthesis of novel 
compounds identified as thiophene chalcones, 2-acetylated pyrazoline derivatives 
and substituted 1,5-benzodiazepines and their biological activities against fungal and 
HIV which have not been reported in any previous work so far. Moreover, some 
thiophene chalcones (series 2 and 3) have been synthesized but no report on the 
biological activity against fungal has appeared in the scientific database. The present 
research for new drugs development used as antifungal and anti-HIV is highly 
significant as it can potentially help to solve the problems related to existing drugs.
1.3 Objectives of Study
The objectives of this research are :
1. To synthesize heterocyclic ketones by using Friedel-Crafts acylation.
2. To synthesize thiophene chalcones, its derivatives carrying 2-acetylated 
pyrazoline and 1,5-benzodiazepines derivatives.
53. To characterize the synthetical compounds by spectroscopic techniques.
4. To evaluate the bioactivity of the synthetical compounds using antifungal and 
anti-HIV-1 RT assays.
1.4 Scope of Study
This thesis is divided into four parts. Part one is focusing on the synthesis of
3-acetyl-2,5-dichlorothiophene and 2-acetyl-5-chlorothiophene as starting material 
for series one by Friedel-Crafts acylation. Then thiophene chalcones were 
synthesized through Claisen-Schmidt method in the presence o f base catalyst. Part 
two is focusing on the synthesis of A-acetylated pyrazoline derivatives using 
cyclization of thiophene chalcones with hydrazine hydrate in glacial acetic acid by 
refluxing. Part three focused on synthesizing 4-methyl-1,3,4,5-tetrahydro-2H-1,5- 
benzodiazepin-2-one as starting material. Then the latter was cyclized with 
appropriate acid chloride to substituted 1,5-benzodiazepines by refluxing in presence 
of anhydrous tetrahydrofuran and triethylamine. All these compounds were 
established using spectroscopic techniques including Nuclear Magnetic Resonance 
(NMR), Infrared Spectroscopy (IR) and electrospray ionization mass spectrometry 
(ESI- MS) for series one.
Finally, the biological activities including antifungal of the series (two and 
three) and anti-HIV-1 RT of 1,5-benzodiazepines derivatives (series four). The 
antimicrobial activity was evaluated against antifungal by microdilution technique 
for determination of minimum inhibitory concentration (MIC). Fourteen selected 
compounds of 1,5-benzodiazepines derivatives were tested against HIV-1 RT, 
inhibition concentration at 50% (IC50) was calculated using serial dilution method.
61.5 Significance of Study
Many people suffer from some diseases that may result from fungal infections 
or HIV if they do not take safety and prevention. Multidrug-resistant (fungals and 
HIV) are well known to have undesirable side effects which can delay recovery and 
may lead to a relapse of the patient.
Previous studies have been carried out on heterocyclic compounds, especially 
carrying sulfur as thiophene chalcone (Tomar et al., 2007); (Bag et al., 2009); 
(Kumar et al., 2013a); (Mazimba, 2015) or a ring containing multiple nitrogen such 
as pyrazole (Kumar et al., 2013d); (Zayane et al., 2015); (Yusuf and Jain, 2012) or 
benzodiazepine (Brase et al., 2002) displayed promising results for fungi or anti- 
HIV-1 RT. In this study, it was observed that the effect of substituents and type on 
biological activity either on phenyl ring in series of thiophene chalcones with its 
derivatives or in a series of benzodiazepines derivatives on benzoyl ring can affect 
antifungal and anti-HIV activities. A synthesis o f these new compounds may lead to 
bioactive compounds and result into designing other new drugs.
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